Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

1.

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.

Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P.

Cancer Lett. 2009 Jun 8;278(1):73-81. doi: 10.1016/j.canlet.2008.12.028. Epub 2009 Feb 1.

PMID:
19188015
[PubMed - indexed for MEDLINE]
2.

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.

Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G, Altevogt P.

Gynecol Oncol. 2007 Dec;107(3):563-71. Epub 2007 Sep 27.

PMID:
17900673
[PubMed - indexed for MEDLINE]
3.

Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.

Peng P, Yan Y, Keng S.

Oncol Rep. 2011 Mar;25(3):749-62. doi: 10.3892/or.2010.1119. Epub 2010 Dec 22.

PMID:
21181093
[PubMed - indexed for MEDLINE]
4.

Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.

Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG.

J Immunol. 2006 Feb 1;176(3):1375-85.

PMID:
16424164
[PubMed - indexed for MEDLINE]
Free Article
5.

Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis.

Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B.

Int J Cancer. 2010 May 1;126(9):2090-101. doi: 10.1002/ijc.24886.

PMID:
19739074
[PubMed - indexed for MEDLINE]
6.

Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.

Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grünberg J, Honer M, Schubiger PA, Altevogt P, Krüger A.

Cancer Res. 2006 Jan 15;66(2):936-43.

PMID:
16424028
[PubMed - indexed for MEDLINE]
Free Article
7.

Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells.

Gutwein P, Stoeck A, Riedle S, Gast D, Runz S, Condon TP, Marmé A, Phong MC, Linderkamp O, Skorokhod A, Altevogt P.

Clin Cancer Res. 2005 Apr 1;11(7):2492-501.

PMID:
15814625
[PubMed - indexed for MEDLINE]
Free Article
8.

Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy.

Massazza G, Tomasoni A, Lucchini V, Allavena P, Erba E, Colombo N, Mantovani A, D'Incalci M, Mangioni C, Giavazzi R.

Int J Cancer. 1989 Sep 15;44(3):494-500.

PMID:
2777413
[PubMed - indexed for MEDLINE]
9.

Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy.

Manenti L, Riccardi E, Marchini S, Naumova E, Floriani I, Garofalo A, Dossi R, Marrazzo E, Ribatti D, Scanziani E, Bani M, Belotti D, Broggini M, Giavazzi R.

Mol Cancer Ther. 2005 May;4(5):715-25.

PMID:
15897235
[PubMed - indexed for MEDLINE]
Free Article
10.

Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.

Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G.

Cancer Res. 2005 Jun 15;65(12):5238-47.

PMID:
15958569
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.

Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marmé F, Sültmann H, Altevogt P.

Gynecol Oncol. 2011 Aug;122(2):437-46. doi: 10.1016/j.ygyno.2011.04.035. Epub 2011 May 20.

PMID:
21601258
[PubMed - indexed for MEDLINE]
12.

[Isolation, identification and clinical significance of ascites-derived exosomes from patients with ovarian epithelial cancer].

Peng P, You Y, Shen K.

Zhonghua Fu Chan Ke Za Zhi. 2009 Apr;44(4):268-72. Chinese.

PMID:
19570464
[PubMed - indexed for MEDLINE]
13.

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Taylor DD, Gercel-Taylor C.

Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Erratum in: Gynecol Oncol. 2010 Jan;116(1):153.

PMID:
18589210
[PubMed - indexed for MEDLINE]
14.

Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice.

Veatch AL, Carson LF, Ramakrishnan S.

Clin Exp Metastasis. 1995 May;13(3):165-72.

PMID:
7750204
[PubMed - indexed for MEDLINE]
15.

Malignant effusions and immunogenic tumour-derived exosomes.

Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L.

Lancet. 2002 Jul 27;360(9329):295-305.

PMID:
12147373
[PubMed - indexed for MEDLINE]
16.

Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations.

Katz E, Skorecki K, Tzukerman M.

Clin Cancer Res. 2009 Jan 1;15(1):70-80. doi: 10.1158/1078-0432.CCR-08-1233.

PMID:
19118034
[PubMed - indexed for MEDLINE]
Free Article
17.

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.

Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ.

BMC Cancer. 2009 Jul 20;9:244. doi: 10.1186/1471-2407-9-244.

PMID:
19619303
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effects of cimetidine on tumor growth and immune function in nude mice bearing human ovarian carcinoma.

Kikuchi Y, Oomori K, Kizawa I, Kato K.

J Natl Cancer Inst. 1985 Feb;74(2):495-8.

PMID:
3871872
[PubMed - indexed for MEDLINE]
19.

Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice.

Molpus KL, Koelliker D, Atkins L, Kato DT, Buczek-Thomas J, Fuller AF Jr, Hasan T.

Int J Cancer. 1996 Nov 27;68(5):588-95.

PMID:
8938139
[PubMed - indexed for MEDLINE]
20.

Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients.

Oppitz M, Möbus V, Brock S, Drews U.

Gynecol Oncol. 2002 Apr;85(1):159-64.

PMID:
11925137
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk